SANUWAVE Health, Inc.
SNWV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $33 | $20 | $17 | $13 |
| % Growth | 60% | 21.8% | 28.7% | – |
| Cost of Goods Sold | $8 | $6 | $4 | $5 |
| Gross Profit | $25 | $14 | $12 | $8 |
| % Margin | 75.2% | 70.4% | 74.1% | 61.7% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $11 | $9 | $13 | $12 |
| SG&A Expenses | $18 | $14 | $20 | $20 |
| Sales & Mktg Exp. | $6 | $5 | $7 | $9 |
| Other Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Expenses | $19 | $15 | $21 | $22 |
| Operating Income | $5 | -$1 | -$9 | -$14 |
| % Margin | 16.6% | -2.6% | -53.5% | -108.7% |
| Other Income/Exp. Net | -$37 | -$25 | -$1 | -$13 |
| Pre-Tax Income | -$31 | -$26 | -$10 | -$27 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$31 | -$26 | -$10 | -$27 |
| % Margin | -96.1% | -126.5% | -61.5% | -209.5% |
| EPS | -7.03 | -12.19 | -7.02 | -19.72 |
| % Growth | 42.3% | -73.6% | 64.4% | – |
| EPS Diluted | -7.03 | -12.19 | -7.02 | -19.72 |
| Weighted Avg Shares Out | 4 | 2 | 1 | 1 |
| Weighted Avg Shares Out Dil | 4 | 2 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $14 | $16 | $14 | $7 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$17 | -$9 | $5 | -$19 |
| % Margin | -50.8% | -44.9% | 28.6% | -145.3% |